Martel Hammer Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-12-2024
- Paid Up Capital ₹ 0.50 M
as on 24-12-2024
- Company Age 47 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.54 M
as on 24-12-2024
- Satisfied Charges ₹ 2.18 M
as on 24-12-2024
- Revenue -86.11%
(FY 2022)
- Profit -119.49%
(FY 2022)
- Ebitda -202.28%
(FY 2022)
- Net Worth -3.31%
(FY 2022)
- Total Assets -6.19%
(FY 2022)
About Martel Hammer Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.54 M. The company has closed loans amounting to ₹2.18 M, as per Ministry of Corporate Affairs (MCA) records.
Prabhudas Gohil and Kalpana Umakanth serve as directors at the Company.
- CIN/LLPIN
U24230MH1977PTC019462
- Company No.
019462
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 1977
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Martel Hammer Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhudas Gohil  | Director | 15-Jan-1992 | Current |
| Kalpana Umakanth | Director | 15-Apr-2013 | Current |
Financial Performance of Martel Hammer Pharmaceuticals.
Martel Hammer Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 86.11% decrease. The company also saw a substantial fall in profitability, with a 119.49% decrease in profit. The company's net worth dipped by a decrease of 3.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Martel Hammer Pharmaceuticals?
In 2020, Martel Hammer Pharmaceuticals had a promoter holding of 99.96% and a public holding of 0.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Walter Bushnell Lifescience Private LimitedActive 2 years 10 monthsPrabhudas Gohil and Kalpana Umakanth are mutual person
Walter Bushnell Healthsciences Private LimitedActive 17 years 6 monthsPrabhudas Gohil is a mutual person
Walter Bushnell Biosciences Private LimitedActive 17 years 6 monthsPrabhudas Gohil is a mutual person
Walter Bushnell Research And Development Center Private LimitedActive 1 year 10 monthsPrabhudas Gohil and Kalpana Umakanth are mutual person
Walter Bushnell Services Private LimitedActive 1 year 9 monthsPrabhudas Gohil and Kalpana Umakanth are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Ltd Creation Date: 17 Sep 1986 | ₹1.00 M | Open |
Punjab National Bank Ltd Creation Date: 03 Mar 1981 | ₹0.34 M | Open |
Punjab National Bank Ltd Creation Date: 13 Jul 1977 | ₹0.20 M | Open |
How Many Employees Work at Martel Hammer Pharmaceuticals?
Unlock and access historical data on people associated with Martel Hammer Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Martel Hammer Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Martel Hammer Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
